Katzmann, D. J., Babst, M. & Emr, S. D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106, 145–155 (2001).
Babst, M., Katzmann, D. J., Snyder, W. B., Wendland, B. & Emr, S. D. Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Dev. Cell 3, 283–289 (2002).
Babst, M., Katzmann, D. J., Estepa-Sabal, E. J., Meerloo, T. & Emr, S. D. Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev. Cell 3, 271–282 (2002). References 1–3 identify ESCRT-I–III through genetic and biochemical analyses of Saccharomyces cerevisiae vacuolar protein sorting mutants.
Hurley, J. H. & Hanson, P. I. Membrane budding and scission by the ESCRT machinery: it’s all in the neck. Nat. Rev. Mol. Cell Biol. 11, 556–566 (2010).
Henne, W. M., Stenmark, H. & Emr, S. D. Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb. Perspect. Biol. 5, a016766 (2013).
Schoneberg, J., Lee, I. H., Iwasa, J. H. & Hurley, J. H. Reverse-topology membrane scission by the ESCRT proteins. Nat. Rev. Mol. Cell Biol. 18, 5–17 (2017).
McCullough, J., Frost, A. & Sundquist, W. I. Structures, functions, and dynamics of ESCRT-III/Vps4 membrane remodeling and fission complexes. Annu. Rev. Cell Dev. Biol. 34, 85–109 (2018).
Allison, R. et al. An ESCRT–spastin interaction promotes fission of recycling tubules from the endosome. J. Cell Biol. 202, 527–543 (2013).
Mast, F. D. et al. ESCRT-III is required for scissioning new peroxisomes from the endoplasmic reticulum. J. Cell Biol. 217, 2087–2102 (2018).
McCullough, J. et al. Structure and membrane remodeling activity of ESCRT-III helical polymers. Science 350, 1548–1551 (2015).
Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244–1247 (2008).
Stuffers, S., Sem Wegner, C., Stenmark, H. & Brech, A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 10, 925–937 (2009).
Strack, B., Calistri, A., Craig, S., Popova, E. & Gottlinger, H. G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114, 689–699 (2003).
von Schwedler, U. K. et al. The protein network of HIV budding. Cell 114, 701–713 (2003).
Christ, L. et al. ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission. J. Cell Biol. 212, 499–513 (2016).
Flower, T. G. et al. A helical assembly of human ESCRT-I scaffolds reverse-topology membrane scission. Nat. Struct. Mol. Biol. 27, 570–580 (2020).
Hanson, P. I., Roth, R., Lin, Y. & Heuser, J. E. Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. J. Cell Biol. 180, 389–402 (2008).
Lata, S. et al. Helical structures of ESCRT-III are disassembled by VPS4. Science 321, 1354–1357 (2008).
Shim, S., Kimpler, L. A. & Hanson, P. I. Structure/function analysis of four core ESCRT-III proteins reveals common regulatory role for extreme C-terminal domain. Traffic 8, 1068–1079 (2007).
Schoneberg, J. et al. ATP-dependent force generation and membrane scission by ESCRT-III and Vps4. Science 362, 1423–1428 (2018).
Azad, K. et al. Structural basis of CHMP2A–CHMP3 ESCRT-III polymer assembly and membrane cleavage. Nat. Struct. Mol. Biol. 30, 81–90 (2023).
Yang, B., Stjepanovic, G., Shen, Q., Martin, A. & Hurley, J. H. Vps4 disassembles an ESCRT-III filament by global unfolding and processive translocation. Nat. Struct. Mol. Biol. 22, 492–498 (2015).
Han, H., Monroe, N., Sundquist, W. I., Shen, P. S. & Hill, C. P. The AAA ATPase Vps4 binds ESCRT-III substrates through a repeating array of dipeptide-binding pockets. eLife 6, e31324 (2017).
Raiborg, C. et al. FYVE and coiled-coil domains determine the specific localisation of Hrs to early endosomes. J. Cell Sci. 114, 2255–2263 (2001).
Wenzel, E. M. et al. Concerted ESCRT and clathrin recruitment waves define the timing and morphology of intraluminal vesicle formation. Nat. Commun. 9, 2932 (2018).
Bache, K. G., Raiborg, C., Mehlum, A. & Stenmark, H. STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes. J. Biol. Chem. 278, 12513–12521 (2003).
Ren, X. & Hurley, J. H. VHS domains of ESCRT-0 cooperate in high-avidity binding to polyubiquitinated cargo. EMBO J. 29, 1045–1054 (2010).
Raiborg, C. et al. Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat. Cell Biol. 4, 394–398 (2002).
Katzmann, D. J., Stefan, C. J., Babst, M. & Emr, S. D. Vps27 recruits ESCRT machinery to endosomes during MVB sorting. J. Cell Biol. 162, 413–423 (2003).
Bache, K. G., Brech, A., Mehlum, A. & Stenmark, H. Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J. Cell Biol. 162, 435–442 (2003).
Liu, X. M. et al. ESCRTs cooperate with a selective autophagy receptor to mediate vacuolar targeting of soluble cargos. Mol. Cell 59, 1035–1042 (2015).
Kostelansky, M. S. et al. Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer. Cell 129, 485–498 (2007).
Wunderley, L., Brownhill, K., Stefani, F., Tabernero, L. & Woodman, P. The molecular basis for selective assembly of the UBAP1-containing endosome-specific ESCRT-I complex. J. Cell Sci. 127, 663–672 (2014).
Boura, E. et al. Solution structure of the ESCRT-I and -II supercomplex: implications for membrane budding and scission. Structure 20, 874–886 (2012).
Wollert, T. & Hurley, J. H. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464, 864–869 (2010).
Liese, S. et al. Protein crowding mediates membrane remodeling in upstream ESCRT-induced formation of intraluminal vesicles. Proc. Natl Acad. Sci. USA 117, 28614–28624 (2020).
Teis, D., Saksena, S., Judson, B. L. & Emr, S. D. ESCRT-II coordinates the assembly of ESCRT-III filaments for cargo sorting and multivesicular body vesicle formation. EMBO J. 29, 871–883 (2010).
Babst, M., Sato, T. K., Banta, L. M. & Emr, S. D. Endosomal transport function in yeast requires a novel AAA-type ATPase, Vps4p. EMBO J. 16, 1820–1831 (1997).
Stuchell-Brereton, M. D. et al. ESCRT-III recognition by VPS4 ATPases. Nature 449, 740–744 (2007).
Adell, M. A. Y. et al. Recruitment dynamics of ESCRT-III and Vps4 to endosomes and implications for reverse membrane budding. eLife 6, e31652 (2017).
van Niel, G., D’Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228 (2018).
Wang, L., Klionsky, D. J. & Shen, H. M. The emerging mechanisms and functions of microautophagy. Nat. Rev. Mol. Cell Biol. 24, 186–203 (2023).
Li, J. & Hochstrasser, M. Selective microautophagy of proteasomes is initiated by ESCRT-0 and is promoted by proteasome ubiquitylation. J. Cell Sci. 135, jcs259393 (2022).
Yang, X. et al. TORC1 regulates vacuole membrane composition through ubiquitin- and ESCRT-dependent microautophagy. J. Cell Biol. 219, e201902127 (2020).
Mejlvang, J. et al. Starvation induces rapid degradation of selective autophagy receptors by endosomal microautophagy. J. Cell Biol. 217, 3640–3655 (2018).
Loi, M., Raimondi, A., Morone, D. & Molinari, M. ESCRT-III-driven piecemeal micro-ER-phagy remodels the ER during recovery from ER stress. Nat. Commun. 10, 5058 (2019).
Liao, Y. C. et al. COPII with ALG2 and ESCRTs control lysosome-dependent microautophagy of ER exit sites. Dev. Cell 59, 1410–1424.e1414 (2024).
Prashar, A. et al. Lysosomes drive the piecemeal removal of mitochondrial inner membrane. Nature 632, 1110–1117 (2024).
Carlton, J. G. & Martin-Serrano, J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316, 1908–1912 (2007).
Morita, E. et al. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 26, 4215–4227 (2007). References 49,50 demonstrate the importance of ESCRTs for cytokinetic abscission and show that ALIX and TSG101 are recruited to the midbody by binding to CEP55.
Lie-Jensen, A. et al. Centralspindlin recruits ALIX to the midbody during cytokinetic abscission in Drosophila via a mechanism analogous to virus budding. Curr. Biol. 29, 3538–3548.e7 (2019).
Guizetti, J. et al. Cortical constriction during abscission involves helices of ESCRT-III-dependent filaments. Science 331, 1616–1620 (2011).
Elia, N., Sougrat, R., Spurlin, T. A., Hurley, J. H. & Lippincott-Schwartz, J. Dynamics of endosomal sorting complex required for transport (ESCRT) machinery during cytokinesis and its role in abscission. Proc. Natl Acad. Sci. USA 108, 4846–4851 (2011).
Goliand, I. et al. Resolving ESCRT-III spirals at the intercellular bridge of dividing cells using 3D STORM. Cell Rep. 24, 1756–1764 (2018).
Addi, C. et al. The Flemmingsome reveals an ESCRT-to-membrane coupling via ALIX/syntenin/syndecan-4 required for completion of cytokinesis. Nat. Commun. 11, 1941 (2020).
Mierzwa, B. E. et al. Dynamic subunit turnover in ESCRT-III assemblies is regulated by Vps4 to mediate membrane remodelling during cytokinesis. Nat. Cell Biol. 19, 787–798 (2017).
Vietri, M. et al. Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing. Nature 522, 231–235 (2015).
Olmos, Y., Hodgson, L., Mantell, J., Verkade, P. & Carlton, J. G. ESCRT-III controls nuclear envelope reformation. Nature 522, 236–239 (2015). References 57,58 demonstrate that ESCRT-III mediates closure of holes in the reformed nuclear envelopes during mititoc exit, that CHMP7 recruits ESCRT-III to the reforming nuclear envelope and that the ESCRT-III protein IST1 recruits spastin to sever spindle microtubules.
Olmos, Y., Perdrix-Rosell, A. & Carlton, J. G. Membrane binding by CHMP7 coordinates ESCRT-III-dependent nuclear envelope reformation. Curr. Biol. 26, 2635–2641 (2016).
von Appen, A. et al. LEM2 phase separation promotes ESCRT-mediated nuclear envelope reformation. Nature 582, 115–118 (2020).
Webster, B. M., Colombi, P., Jager, J. & Lusk, C. P. Surveillance of nuclear pore complex assembly by ESCRT-III/Vps4. Cell 159, 388–401 (2014).
Raab, M. et al. ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death. Science 352, 359–362 (2016).
Denais, C. M. et al. Nuclear envelope rupture and repair during cancer cell migration. Science 352, 353–358 (2016). References 62,63 demonstrate that ESCRT-III, recruited by CHMP7, repairs the ruptured nuclear envelope.
Coyne, A. N. et al. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med. 13, eabe1923 (2021).
Vietri, M. et al. Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation. Nat. Cell Biol. 22, 856–867 (2020).
Shukla, S., Larsen, K. P., Ou, C., Rose, K. & Hurley, J. H. In vitro reconstitution of calcium-dependent recruitment of the human ESCRT machinery in lysosomal membrane repair. Proc. Natl Acad. Sci. USA 119, e2205590119 (2022).
Jimenez, A. J. et al. ESCRT machinery is required for plasma membrane repair. Science 343, 1247136 (2014). This study demonstrates that ESCRTs are recruited to wounds in the plasma membrane to mediate their repair, and that extracellular buds are detected at the sites of ESCRT recruitment.
Skowyra, M. L., Schlesinger, P. H., Naismith, T. V. & Hanson, P. I. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science 360, eaar5078 (2018).
Radulovic, M. et al. ESCRT‐mediated lysosome repair precedes lysophagy and promotes cell survival. EMBO J. 37, e99753 (2018). References 68,69 show that Ca2+ release from damaged lysosomes triggers ESCRT recruitment, which mediates their repair and promotes cell viability.
Chen, W., Motsinger, M. M., Li, J., Bohannon, K. P. & Hanson, P. I. Ca2+-sensor ALG-2 engages ESCRTs to enhance lysosomal membrane resilience to osmotic stress. Proc. Natl Acad. Sci. USA 121, e2318412121 (2024).
Katoh, K. et al. The penta-EF-hand protein ALG-2 interacts directly with the ESCRT-I component TSG101, and Ca2+-dependently co-localizes to aberrant endosomes with dominant-negative AAA ATPase SKD1/Vps4B. Biochem. J 391, 677–685 (2005).
Missotten, M., Nichols, A., Rieger, K. & Sadoul, R. Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ. 6, 124–129 (1999).
Herbst, S. et al. LRRK2 activation controls the repair of damaged endomembranes in macrophages. EMBO J. 39, e104494 (2020).
Hung, Y. H., Chen, L. M., Yang, J. Y. & Yang, W. Y. Spatiotemporally controlled induction of autophagy-mediated lysosome turnover. Nat. Commun. 4, 2111 (2013).
Maejima, I. et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J. 32, 2336–2347 (2013).
Gahlot, P. et al. Lysosomal damage sensing and lysophagy initiation by SPG20-ITCH. Mol. Cell 84, 1556–1569 e1510 (2024).
Vargas, J. N. S., Hamasaki, M., Kawabata, T., Youle, R. J. & Yoshimori, T. The mechanisms and roles of selective autophagy in mammals. Nat. Rev. Mol. Cell Biol. 24, 167–185 (2023).
Takahashi, Y. et al. An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure. Nat. Commun. 9, 2855 (2018).
Zhen, Y. et al. ESCRT-mediated phagophore sealing during mitophagy. Autophagy 16, 826–841 (2020). References 78,79 show that ESCRT-I and ESCRT-III mediate closure of the autophagosome and that this promotes autophagic flux.
Ye, Y. et al. Identification of membrane curvature sensing motifs essential for VPS37A phagophore recruitment and autophagosome closure. Commun. Biol. 7, 334 (2024).
Javed, R. et al. Mammalian ATG8 proteins maintain autophagosomal membrane integrity through ESCRTs. EMBO J. 42, e112845 (2023).
Klionsky, D. J. et al. Autophagy in major human diseases. EMBO J. 40, e108863 (2021).
Vietri, M., Radulovic, M. & Stenmark, H. The many functions of ESCRTs. Nat. Rev. Mol. Cell Biol. 21, 25–42 (2020).
Votteler, J. & Sundquist, W. I. Virus budding and the ESCRT pathway. Cell Host Microbe 14, 232–241 (2013).
VerPlank, L. et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc. Natl Acad. Sci. USA 98, 7724–7729 (2001).
Garrus, J. E. et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55–65 (2001).
Martin-Serrano, J., Zang, T. & Bieniasz, P. D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7, 1313–1319 (2001). References 85–87 demonstrate that the ESCRT-I subunit TSG101, through interaction with a PTAP motif in viral Gag proteins, mediates viral budding.
Johnson, D. S., Bleck, M. & Simon, S. M. Timing of ESCRT-III protein recruitment and membrane scission during HIV-1 assembly. eLife 7, e36221 (2018).
Jackson, C. E., Scruggs, B. S., Schaffer, J. E. & Hanson, P. I. Effects of inhibiting VPS4 support a general role for ESCRTs in extracellular vesicle biogenesis. Biophys. J. 113, 1342–1352 (2017).
Hoffmann, M. A. G. et al. ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines. Cell 186, 2380–2391.e2389 (2023).
Gong, Y. N. et al. ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences. Cell 169, 286–300.e216 (2017).
Yoon, S., Kovalenko, A., Bogdanov, K. & Wallach, D. MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation. Immunity 47, 51–65 e57 (2017).
Ruhl, S. et al. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science 362, 956–960 (2018).
Liao, Y. et al. The Ras GTPase-activating-like protein IQGAP1 bridges Gasdermin D to the ESCRT system to promote IL-1β release via exosomes. EMBO J. 42, e110780 (2023).
Claude-Taupin, A. et al. ATG9A protects the plasma membrane from programmed and incidental permeabilization. Nat. Cell Biol. 23, 846–858 (2021).
Pedrera, L. et al. Ferroptotic pores induce Ca2+ fluxes and ESCRT-III activation to modulate cell death kinetics. Cell Death Differ. 28, 1644–1657 (2021).
Dai, E., Meng, L., Kang, R., Wang, X. & Tang, D. ESCRT-III-dependent membrane repair blocks ferroptosis. Biochem. Biophys. Res. Commun. 522, 415–421 (2020).
Ritter, A. T. et al. ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack. Science 376, 377–382 (2022). This study shows that ESCRT-dependent membrane repair needs to be inhibited in cancer cells for their efficient elimination by cytotoxic T cells.
Stefani, C. et al. LITAF protects against pore-forming protein-induced cell death by promoting membrane repair. Sci. Immunol. 9, eabq6541 (2024).
Li, Z. et al. Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response. Nat. Commun. 13, 6321 (2022). This proof-of-concept study demonstrates the feasibility of concomitant induction of pyroptosis and inhibition of ESCRT-mediated membrane repair for in vivo anti-tumour therapies.
Suda, K. et al. Plasma membrane damage limits re plicative lifespan in yeast and induces premature senescence in human fibroblasts. Nat. Aging 4, 319–335 (2024).
Gros, M. et al. Endocytic membrane repair by ESCRT-III controls antigen export to the cytosol during antigen cross-presentation. Cell Rep. 40, 111205 (2022).
Maminska, A. et al. ESCRT proteins restrict constitutive NF-κB signaling by trafficking cytokine receptors. Sci. Signal. 9, ra8 (2016).
Song, D. et al. PTPN23-dependent ESCRT machinery functions as a cell death checkpoint. Nat. Commun. 15, 10364 (2024).
Zanin, N. et al. STAM and Hrs interact sequentially with IFN-α receptor to control spatiotemporal JAK–STAT endosomal activation. Nat. Cell Biol. 25, 425–438 (2023).
Kvalvaag, A. et al. Clathrin mediates both internalization and vesicular release of triggered T cell receptor at the immunological synapse. Proc. Natl Acad. Sci. USA 120, e2211368120 (2023).
Jiang, C. et al. CRISPR/Cas9 screens reveal multiple layers of B cell CD40 regulation. Cell Rep. 28, 1307–1322.e1308 (2019).
Kuchitsu, Y. et al. STING signalling is terminated through ESCRT-dependent microautophagy of vesicles originating from recycling endosomes. Nat. Cell Biol. 25, 453–466 (2023).
Gentili, M. et al. ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling. Nat. Commun. 14, 611 (2023).
Balka, K. R. et al. Termination of STING responses is mediated via ESCRT-dependent degradation. EMBO J. 42, e112712 (2023). References 108–110 identify the role and mechanism of ESCRT-dependent degradation in termination of cGAS–STING signalling.
Zhang, Z. et al. Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy. Signal Transduct. Target. Ther. 7, 394 (2022).
Liu, Y. et al. Clathrin-associated AP-1 controls termination of STING signalling. Nature 610, 761–767 (2022).
Carlton, J. G., Caballe, A., Agromayor, M., Kloc, M. & Martin-Serrano, J. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. Science 336, 220–225 (2012).
Sadler, J. B. A. et al. A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability. Proc. Natl Acad. Sci. USA 115, E8900–E8908 (2018).
Martin, S. et al. A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements. Science 385, eadj7446 (2024).
Di Bona, M. et al. Micronuclear collapse from oxidative damage. Science 385, eadj8691 (2024). References 115,116 explain the molecular mechanisms underlying destabilization of micronuclei, which involve reactive oxygen species and p62, as well as inhibition of ESCRT-mediated repair of micronuclear membranes.
Guan, L. et al. HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors. Nat. Commun. 13, 4078 (2022).
Tomasich, E. et al. Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer. Transl. Res. 230, 21–33 (2021).
Monypenny, J. et al. ALIX regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation. Cell Rep. 24, 630–641 (2018).
Bernareggi, D. et al. CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity. Nat. Commun. 13, 1899 (2022).
Manteghi, S. et al. Haploinsufficiency of the ESCRT component HD-PTP predisposes to cancer. Cell Rep. 15, 1893–1900 (2016).
Szymanska, E. et al. Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer. EMBO Mol. Med. 12, e10812 (2020).
Neggers, J. E. et al. Synthetic lethal interaction between the ESCRT paralog enzymes VPS4A and VPS4B in cancers harboring loss of chromosome 18q or 16q. Cell Rep. 33, 108493 (2020). References 122,123 uncover the molecular basis of synthetic lethality between VPS4A and VPS4B, and its possible application in anti-cancer therapies.
Xu, Z., Liang, L., Wang, H., Li, T. & Zhao, M. HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein. Biochem. Biophys. Res. Commun. 311, 1057–1066 (2003).
Wittinger, M. et al. hVps37A status affects prognosis and cetuximab sensitivity in ovarian cancer. Clin. Cancer Res. 17, 7816–7827 (2011).
Kolmus, K. et al. Concurrent depletion of Vps37 proteins evokes ESCRT-I destabilization and profound cellular stress responses. J. Cell Sci. 134, jcs250951 (2021).
Migliano, S. M. et al. Removal of hypersignaling endosomes by simaphagy. Autophagy 20, 769–791 (2024).
Takahashi, Y. et al. VPS37A directs ESCRT recruitment for phagophore closure. J. Cell Biol. 218, 3336–3354 (2019).
Schultz, D. F. et al. Loss of HD-PTP function results in lipodystrophy, defective cellular signaling and altered lipid homeostasis. J. Cell Sci. 137, jcs262032 (2024).
Sekar, R. et al. Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomes. Cell Metab. 34, 2047 (2022).
Das, D. et al. VPS4A is the selective receptor for lipophagy in mice and humans. Mol. Cell 84, 4436–4453.e8 (2024).
Skibinski, G. et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37, 806–808 (2005).
Cox, L. E. et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS ONE 5, e9872 (2010). References 132,133 identify mutations in CHMP2B as genetic causes of FTD/ALS.
van der Zee, J. et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum. Mol. Genet. 17, 313–322 (2008).
Urwin, H. et al. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum. Mol. Genet 19, 2228–2238 (2010).
Lee, J. A., Beigneux, A., Ahmad, S. T., Young, S. G. & Gao, F. B. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr. Biol. 17, 1561–1567 (2007).
Gissawong, N. et al. Electrochemical detection of methyl parathion using calix[6]arene/bismuth ferrite/multiwall carbon nanotube-modified fluorine-doped tin oxide electrode. Mikrochim. Acta 189, 461 (2022).
Holm, I. E., Englund, E., Mackenzie, I. R., Johannsen, P. & Isaacs, A. M. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J. Neuropathol. Exp. Neurol. 66, 884–891 (2007).
Jambroes, M., Lamkaddem, M., Stronks, K. & Essink-Bot, M. L. Enumerating the preventive youth health care workforce: Size, composition and regional variation in the Netherlands. Health Policy 119, 1557–1564 (2015).
Ghazi-Noori, S. et al. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brain 135, 819–832 (2012).
West, R. J. H., Ugbode, C., Fort-Aznar, L. & Sweeney, S. T. Neuroprotective activity of ursodeoxycholic acid in CHMP2B(Intron5) models of frontotemporal dementia. Neurobiol. Dis. 144, 105047 (2020).
Belly, A. et al. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. J. Cell Sci. 123, 2943–2954 (2010).
Heffner, C. M., Starling, G. P., Isaacs, A. M. & Carlton, J. G. The ALS- and FTD-associated proteins annexin A11 and CHMP2B act sequentially in membrane repair. Preprint at bioRxiv https://doi.org/10.1101/2024.11.19.624330 (2024).
Baskerville, V., Rapuri, S., Mehlhop, E. & Coyne, A. N. SUN1 facilitates CHMP7 nuclear influx and injury cascades in sporadic amyotrophic lateral sclerosis. Brain 147, 109–121 (2024).
Keeley, O., Mendoza, E., Menon, D. & Coyne, A. N. CHMP2B promotes CHMP7 mediated nuclear pore complex injury in sporadic ALS. Acta Neuropathol. Commun. 12, 199 (2024).
Dubey, S. K., Maulding, K., Sung, H. & Lloyd, T. E. Nucleoporins are degraded via upregulation of ESCRT-III/Vps4 complex in Drosophila models of C9-ALS/FTD. Cell Rep. 40, 111379 (2022).
Frost, B., Bardai, F. H. & Feany, M. B. Lamin dysfunction mediates neurodegeneration in tauopathies. Curr. Biol. 26, 129–136 (2016).
Eftekharzadeh, B. et al. Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease. Neuron 99, 925–940.e927 (2018).
Paonessa, F. et al. Microtubules deform the nuclear membrane and disrupt nucleocytoplasmic transport in tau-mediated frontotemporal dementia. Cell Rep. 26, 582–593.e585 (2019).
Sirtori, R. et al. LINC complex alterations are a key feature of sporadic and familial ALS/FTD. Acta Neuropathol. Commun. 12, 69 (2024).
Sirtori, R. et al. Altered nuclear envelope homeostasis is a key pathogenic event in C9ORF72-linked ALS/FTD. Preprint at bioRxiv https://doi.org/10.1101/2024.02.01.578318 (2024).
Giampetruzzi, A. et al. Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis. Nat. Commun. 10, 3827 (2019).
Ortega, J. A. et al. Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS/FTD C9orf72 toxicity. Neuron 106, 90–107.e113 (2020).
Prissette, M. et al. Disruption of nuclear envelope integrity as a possible initiating event in tauopathies. Cell Rep. 40, 111249 (2022). This study examines the potential for therapeutically modulating ESCRT expression to mitigate nuclear envelope alterations in tauopathy.
Wu, J., Wu, J., Chen, T., Cai, J. & Ren, R. Protein aggregation and its affecting mechanisms in neurodegenerative diseases. Neurochem. Int. 180, 105880 (2024).
Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45–51 (2013).
Uemura, N., Uemura, M. T., Luk, K. C., Lee, V. M. & Trojanowski, J. Q. Cell-to-cell transmission of tau and α-synuclein. Trends Mol. Med. 26, 936–952 (2020).
Peng, C., Trojanowski, J. Q. & Lee, V. M. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 16, 199–212 (2020).
Rose, K. et al. Tau fibrils induce nanoscale membrane damage and nucleate cytosolic tau at lysosomes. Proc. Natl Acad. Sci. USA 121, e2315690121 (2024).
Chen, J. J. et al. Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation. J. Biol. Chem. 294, 18952–18966 (2019).
Filimonenko, M. et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 179, 485–500 (2007).
Liu, G. et al. Endocytosis regulates TDP-43 toxicity and turnover. Nat. Commun. 8, 2092 (2017).
Borland, H. et al. α-Synuclein buildup is alleviated via ESCRT-dependent endosomal degradation brought about by p38MAPK inhibition in cells expressing p25α. J. Biol. Chem. 298, 102531 (2022).
Chou, C. C. et al. Human tNeurons reveal aging-linked proteostasis deficits driving Alzheimer’s phenotypes. Res. Sq. https://doi.org/10.21203/rs.3.rs-4407236/v1 (2024).
Nim, S. et al. Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease. Nat. Commun. 14, 2150 (2023).
Spencer, B. et al. α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease. Hum. Mol. Genet. 25, 1100–1115 (2016). References 166,167 examine modulation of ESCRT–α-synuclein interactions to alleviate neurodegeneration in Parkinson’s disease.
Zenko, D. et al. Monitoring α-synuclein ubiquitination dynamics reveals key endosomal effectors mediating its trafficking and degradation. Sci. Adv. 9, eadd8910 (2023).
Sitron, C. S. et al. α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation. Preprint at bioRxiv https://doi.org/10.1101/2025.01.13.632710 (2025).
Sowada, N. et al. Mutations of PTPN23 in developmental and epileptic encephalopathy. Hum. Genet. 136, 1455–1461 (2017).
Farazi Fard, M. A. et al. Truncating mutations in UBAP1 cause hereditary spastic paraplegia. Am. J. Hum. Genet. 104, 767–773 (2019).
Brugger, M. et al. Bi-allelic variants in SNF8 cause a disease spectrum ranging from severe developmental and epileptic encephalopathy to syndromic optic atrophy. Am. J. Hum. Genet. 111, 594–613 (2024).
Rodger, C. et al. De novo VPS4A mutations cause multisystem disease with abnormal neurodevelopment. Am. J. Hum. Genet. 107, 1129–1148 (2020).
Seu, K. G. et al. VPS4A mutations in humans cause syndromic congenital dyserythropoietic anemia due to cytokinesis and trafficking defects. Am. J. Hum. Genet. 107, 1149–1156 (2020).
Mochida, G. H. et al. CHMP1A encodes an essential regulator of BMI1–INK4A in cerebellar development. Nat. Genet. 44, 1260–1264 (2012).
Coulter, M. E. et al. The ESCRT-III protein CHMP1A mediates secretion of sonic hedgehog on a distinctive subtype of extracellular vesicles. Cell Rep. 24, 973–986.e978 (2018).
Cohen-Barak, E. et al. A homozygous variant in CHMP3 is associated with complex hereditary spastic paraplegia. J. Med. Genet. 60, 233–240 (2023).
Vita, D. J. & Broadie, K. ESCRT-III membrane trafficking misregulation contributes to fragile X syndrome synaptic defects. Sci. Rep. 7, 8683 (2017).
Sears, J. C. & Broadie, K. Fragile X mental retardation protein regulates activity-dependent membrane trafficking and trans-synaptic signaling mediating synaptic remodeling. Front. Mol. Neurosci. 10, 440 (2017).
Sweeney, N. T., Brenman, J. E., Jan, Y. N. & Gao, F. B. The coiled-coil protein shrub controls neuronal morphogenesis in Drosophila. Curr. Biol. 16, 1006–1011 (2006).
Loncle, N., Agromayor, M., Martin-Serrano, J. & Williams, D. W. An ESCRT module is required for neuron pruning. Sci. Rep. 5, 8461 (2015).
Rheinemann, L. et al. RetroCHMP3 blocks budding of enveloped viruses without blocking cytokinesis. Cell 184, 5419–5431.e5416 (2021).
Knyazeva, A. et al. A chemical inhibitor of IST1–CHMP1B interaction impairs endosomal recycling and induces noncanonical LC3 lipidation. Proc. Natl Acad. Sci. USA 121, e2317680121 (2024).
Cowan, A. D. & Ciulli, A. Driving E3 ligase substrate specificity for targeted protein degradation: lessons from nature and the laboratory. Annu. Rev. Biochem. 91, 295–319 (2022).
Krone, M. W. & Crews, C. M. Next steps for targeted protein degradation. Cell Chem. Biol. 32, 219–226 (2024).
Pornillos, O., Alam, S. L., Davis, D. R. & Sundquist, W. I. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol. 9, 812–817 (2002).
Demirov, D. G., Ono, A., Orenstein, J. M. & Freed, E. O. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl Acad. Sci. USA 99, 955–960 (2002).
Ferraiuolo, R. M., Manthey, K. C., Stanton, M. J., Triplett, A. A. & Wagner, K. U. The multifaceted roles of the tumor susceptibility gene 101 (TSG101) in normal development and disease. Cancers 12, 450 (2020).
